Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Global regulators discuss observational studies of real world data for COVID-19 medicines 7 Abril 2020 News Human COVID-19 Essential work to combat the COVID-19 pandemic to continue during EMA's Easter break from 9 to 13 April 2020 7 Abril 2020 News Corporate COVID-19 EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic 6 Abril 2020 Press release Human Medicine shortages Medicines EMA provides recommendations on compassionate use of remdesivir for COVID-19 3 Abril 2020 Press release Human COVID-19 Medicines for use outside the EU International regulators discuss available knowledge supporting COVID-19 medicine development 3 Abril 2020 News Human COVID-19 Medicines Research and development Vaccines COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes 1 Abril 2020 News Human COVID-19 Clinical trials Research and development Regulatory information - 1.6% increase in fees from 1 April 2020 1 Abril 2020 News Corporate Fees EU recommendations for 2020/2021 seasonal flu vaccine composition 1 Abril 2020 News Human Vaccines Advancing regulatory science in the EU – new strategy adopted 31 Marzo 2020 Press release Human Veterinary Corporate Innovation Research and development Update on treatments and vaccines against COVID-19 under development 31 Marzo 2020 Press release Human COVID-19 Medicines Vaccines 1 … 85 86 87 88 89 Page 89 of 380 90 91 92 93 … 380
Global regulators discuss observational studies of real world data for COVID-19 medicines 7 Abril 2020 News Human COVID-19
Essential work to combat the COVID-19 pandemic to continue during EMA's Easter break from 9 to 13 April 2020 7 Abril 2020 News Corporate COVID-19
EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic 6 Abril 2020 Press release Human Medicine shortages Medicines
EMA provides recommendations on compassionate use of remdesivir for COVID-19 3 Abril 2020 Press release Human COVID-19 Medicines for use outside the EU
International regulators discuss available knowledge supporting COVID-19 medicine development 3 Abril 2020 News Human COVID-19 Medicines Research and development Vaccines
COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes 1 Abril 2020 News Human COVID-19 Clinical trials Research and development
Advancing regulatory science in the EU – new strategy adopted 31 Marzo 2020 Press release Human Veterinary Corporate Innovation Research and development
Update on treatments and vaccines against COVID-19 under development 31 Marzo 2020 Press release Human COVID-19 Medicines Vaccines